Zolmitriptan
CAS 139264-17-8
In Stock
Zolmitriptan
Cat. No. ANT-ZLM-009CAS 139264-17-8In Stock
Technical Data
Cat. No.ANT-ZLM-009
CAS139264-17-8
Mol. FormulaC16H21N3O2
Mol. Weight287.36 g/mol
IUPAC(4S)-4-[[3-[2-(dimethylamino)ethyl]-1H-indol-5-yl]methyl]-1,3-oxazolidin-2-one
SMILESO=C1OC[C@H](CC2=CC3=C(NC=C3CCN(C)C)C=C2)N1
InChIInChI=1S/C16H21N3O2/c1-19(2)6-5-12-9-17-15-4-3-11(8-14(12)15)7-13-10-21-16(20)18-13/h3-4,8-9,13,17H,5-7,10H2,1-2H3,(H,18,20)/t13-/m0/s1
InChI KeyULSDMUVEXKOYBU-ZDUSSCGKSA-N
Purity—
Description
Overview
Zolmitriptan, sold under the brand name Zomig among others, is a triptan used in the acute treatment of migraine attacks with or without aura and cluster headaches. It is a selective serotonin receptor agonist of the 1B and 1D subtypes. It was patented in 1990 and approved for medical use in 1997
Anant Labs manufacture and furnish high quality Zolmitriptan impurities for global markets. Our Zolmitriptan EP Impurities are used by API manufacturers and fully integrated pharmaceutical companies worldwide.
Synonyms
(4S)-4-[[3-[2-(Dimethylamino)ethyl]-1H-indol-5-yl]methyl-2-oxazolidinoneZomig(S)-4-[[3-[2-(Dimethylamino)ethyl]indol-5-yl]methyl]-2-oxazolidinone2-Oxazolidinone, 4-[[3-[2-(dimethylamino)ethyl]-1H-indol-5-yl]methyl]-, (S)- (USP)zolmitriptan139264-17-8ZomigoroZomig-ZMT311C90AscoTop
